| Year |
Citation |
Score |
| 2023 |
He Y, Krämer SD, Grether U, Wittwer MB, Collin L, Kuhn B, Topp A, Heer D, O'Hara F, Honer M, Pavlovic A, Richter H, Ritter M, Rombach D, Keller C, ... ... Mu L, et al. Identification of ()-[F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug Development. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 38164615 DOI: 10.2967/jnumed.123.266426 |
0.309 |
|
| 2022 |
He Y, Gobbi LC, Herde AM, Rombach D, Ritter M, Kuhn B, Wittwer MB, Heer D, Hornsperger B, Bell C, O'Hara F, Benz J, Honer M, Keller C, Collin L, ... ... Mu L, et al. Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold. Nuclear Medicine and Biology. 24-32. PMID 35248850 DOI: 10.1016/j.nucmedbio.2022.02.002 |
0.304 |
|
| 2022 |
He Y, Schild M, Grether U, Benz J, Leibrock L, Heer D, Topp A, Collin L, Kuhn B, Wittwer M, Keller C, Gobbi LC, Schibli R, Mu L. Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging. Journal of Medicinal Chemistry. PMID 35089028 DOI: 10.1021/acs.jmedchem.1c01706 |
0.331 |
|
| 2020 |
Mu L, Krämer SD, Ahmed H, Gruber S, Geistlich S, Schibli R, Ametamey SM. Neuroimaging with Radiopharmaceuticals Targeting the Glutamatergic System. Chimia. 74: 960-967. PMID 33357289 DOI: 10.2533/chimia.2020.960 |
0.309 |
|
| 2020 |
Mu L, Krämer SD, Warnock GI, Haider A, Bengs S, Cartolano G, Bräm DS, Keller C, Schibli R, Ametamey SM, Kaufmann PA, Gebhard C. [C]mHED PET follows a two-tissue compartment model in mouse myocardium with norepinephrine transporter (NET)-dependent uptake, while [F]LMI1195 uptake is NET-independent. Ejnmmi Research. 10: 114. PMID 32990788 DOI: 10.1186/s13550-020-00700-7 |
0.31 |
|
| 2020 |
Haider A, Gobbi LC, Kretz J, Ullmer C, Brink A, Honer M, Woltering TJ, Muri D, Iding H, Bürkler M, Binder M, Bartelmus C, Knuesel I, Pacher P, Müller Herde A, ... ... Mu L, et al. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. Journal of Medicinal Chemistry. PMID 32787079 DOI: 10.1021/acs.jmedchem.0c00778 |
0.358 |
|
| 2020 |
Ahmed H, Wallimann R, Haider A, Hosseini V, Gruber S, Robledo M, Nguyen TAN, Herde AM, Iten I, Keller C, Vogel V, Schibli R, Wuensch B, Mu L, Ametamey SM. Preclinical Development of F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-D-Aspartate Receptors and its Utility as a Biomarker for Amyotrophic Lateral Sclerosis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32737247 DOI: 10.2967/Jnumed.120.246785 |
0.375 |
|
| 2019 |
Haider A, Kretz J, Gobbi LC, Ahmed H, Atz K, Bürkler M, Bartelmus C, Fingerle J, Guba W, Ullmer C, Honer M, Knuesel I, Weber M, Brink A, Müller Herde A, ... ... Mu L, et al. Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. Journal of Medicinal Chemistry. PMID 31751140 DOI: 10.1021/acs.jmedchem.9b01280 |
0.381 |
|
| 2019 |
Ahmed H, Haider A, Varisco J, Stanković M, Wallimann R, Gruber S, Iten I, Häne S, Müller Herde A, Keller C, Schibli R, Schepmann D, Mu L, Wünsch B, Ametamey SM. Structure-Affinity Relationships of 2,3,4,5-Tetrahydro-1-3-benzazepine and 6,7,8,9-Tetrahydro-5-benzo[7]annulen-7-amine Analogues and the Discovery of a Radiofluorinated 2,3,4,5-Tetrahydro-1-3-benzazepine Congener for Imaging GluN2B Subunit-Containing -Methyl-d-aspartate Receptors. Journal of Medicinal Chemistry. PMID 31657559 DOI: 10.1021/acs.jmedchem.9b00812 |
0.372 |
|
| 2019 |
Haider A, Müller Herder A, Krämer SD, Varisco J, Keller C, Frauenknecht K, Auberson YP, Temme L, Robaa D, Sippl W, Schibli R, Wünsch B, Mu L, Ametamey SM. Preclinical Evaluation of Benzazepine-Based PET Radioligands - and -C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and Tightrope Walk between GluN2B- and Sigma1 Receptor-Targeted PET Imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30683765 DOI: 10.2967/Jnumed.118.221051 |
0.352 |
|
| 2018 |
Müller Herde A, Boss SD, He Y, Schibli R, Mu L, Ametamey SM. Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [F]PSS232 in the Rat Brain. Pharmaceuticals (Basel, Switzerland). 11. PMID 30158438 DOI: 10.3390/ph11030083 |
0.317 |
|
| 2018 |
Haider A, Iten I, Ahmed H, Müller Herder A, Gruber S, Krämer SD, Keller C, Schibli R, Wünsch B, Mu L, Ametamey SM. Identification and Preclinical Evaluation of a Radiofluorinated Benzazepine Derivative for Imaging the GluN2B Subunit of the Ionotropic NMDA Receptor. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30030340 DOI: 10.2967/jnumed.118.212134 |
0.348 |
|
| 2018 |
Krämer SD, Betzel T, Mu L, Haider A, Herde AM, Boninsegni AK, Keller C, Szermerski M, Schibli R, Wünsch B, Ametamey SM. Evaluation of C-Me-NB1 as a Potential PET Radioligand for Measuring GluN2B-Containing NMDA Receptors, Drug Occupancy, and Receptor Cross Talk. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 59: 698-703. PMID 29191857 DOI: 10.2967/jnumed.117.200451 |
0.344 |
|
| 2017 |
Warnock G, Sommerauer M, Mu L, Pla Gonzalez G, Geistlich S, Treyer V, Schibli R, Buck A, Krämer SD, Ametamey SM. A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29177707 DOI: 10.1007/S00259-017-3879-X |
0.338 |
|
| 2016 |
Mu L, Müller Herde A, Rüefli PM, Sladojevich F, Milicevic Sephton S, Krämer SD, Thompson AJ, Schibli R, Ametamey SM, Lochner M. Synthesis and Pharmacological Evaluation of [(11)C]granisetron and [(18)F]fluoropalonosetron as PET Probes for 5-HT3 Receptor Imaging. Acs Chemical Neuroscience. PMID 27571447 DOI: 10.1021/acschemneuro.6b00192 |
0.426 |
|
| 2016 |
Haider A, Müller Herde A, Slavik R, Weber M, Mugnaini C, Ligresti A, Schibli R, Mu L, Mensah Ametamey S. Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging. Frontiers in Neuroscience. 10: 350. PMID 27512365 DOI: 10.3389/fnins.2016.00350 |
0.351 |
|
| 2016 |
Slavik R, Müller Herde A, Haider A, Krämer SD, Weber M, Schibli R, Ametamey SM, Mu L. Discovery of a Fluorinated 4-Oxo-Quinoline Derivative as a Potential PET Radiotracer for Imaging CB2 Receptor. Journal of Neurochemistry. PMID 27385045 DOI: 10.1111/jnc.13716 |
0.308 |
|
| 2015 |
Müller Herde A, Keller C, Milicevic Sephton S, Mu L, Schibli R, Ametamey SM, Krämer SD. Quantitative positron emission tomography of mGluR5 in rat brain with [(18) F]PSS232 at minimal invasiveness and reduced model complexity. Journal of Neurochemistry. 133: 330-42. PMID 25439096 DOI: 10.1111/jnc.13001 |
0.304 |
|
| 2015 |
Sephton SM, Herde AM, Mu L, Keller C, Rüdisühli S, Auberson Y, Schibli R, Krämer SD, Ametamey SM. Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5). European Journal of Nuclear Medicine and Molecular Imaging. 42: 128-37. PMID 25139517 DOI: 10.1007/s00259-014-2883-7 |
0.339 |
|
| 2014 |
Mu L, Slavik R, Müller A, Popaj K, Cermak S, Weber M, Schibli R, Krämer SD, Ametamey SM. Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor. Pharmaceuticals (Basel, Switzerland). 7: 339-52. PMID 24662272 DOI: 10.3390/ph7030339 |
0.323 |
|
| 2013 |
Mu L, Bieri D, Slavik R, Drandarov K, Müller A, Cermak S, Weber M, Schibli R, Krämer SD, Ametamey SM. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor. Journal of Neurochemistry. 126: 616-24. PMID 23795580 DOI: 10.1111/jnc.12354 |
0.325 |
|
| 2012 |
Sephton SM, Dennler P, Leutwiler DS, Mu L, Wanger-Baumann CA, Schibli R, Krämer SD, Ametamey SM. Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5. American Journal of Nuclear Medicine and Molecular Imaging. 2: 14-28. PMID 23133799 |
0.33 |
|
| 2012 |
Sephton SM, Dennler P, Leutwiler DS, Mu L, Schibli R, Krämer SD, Ametamey SM. Development of [(18)F]-PSS223 as a PET tracer for imaging of metabotropic glutamate receptor subtype 5 (mGluR5). Chimia. 66: 201-4. PMID 22613149 DOI: 10.2533/chimia.2012.201 |
0.371 |
|
| 2011 |
Wanger-Baumann CA, Mu L, Honer M, Belli S, Alf MF, Schubiger PA, Krämer SD, Ametamey SM. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5). Neuroimage. 56: 984-91. PMID 21406237 DOI: 10.1016/j.neuroimage.2011.03.024 |
0.337 |
|
| 2010 |
Baumann CA, Mu L, Wertli N, Krämer SD, Honer M, Schubiger PA, Ametamey SM. Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands. Bioorganic & Medicinal Chemistry. 18: 6044-54. PMID 20634080 DOI: 10.1016/j.bmc.2010.06.070 |
0.315 |
|
| 2003 |
Lochner M, Mu L, Woggon W. Remote Effects Modulating the Spin Equilibrium of the Resting State of Cytochrome P450cam –An Investigation Using Active Site Analogues Advanced Synthesis & Catalysis. 345: 743-765. DOI: 10.1002/ADSC.200303011 |
0.39 |
|
| Show low-probability matches. |